Martin Wiesjahn

Martin Wiesjahn

Auto-generated profile, based on publicly available information

Martin Wiesjahn

Department of Psychology, Clinical Psychology and Psychotherapy, Philipps-University Marburg , Marburg, Hesse

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 July 2014 in British Journal of Clinical Psychology
Verified
Journal Article
Closed access
PDF file
EJEsther Jung
Esther Jung
MWMartin Wiesjahn
Martin Wiesjahn
WRWinfried Rief
Winfried Rief
TLTania M. Lincoln
Tania M. Lincoln

1 March 2016 in Journal of Behavior Therapy and Experimental Psychiatry
Verified
Journal Article
Closed access
MWMartin Wiesjahn
Martin Wiesjahn
EJEsther Jung
Esther Jung
JKJulian D. Kremser
Julian D. Kremser
WRWinfried Rief
Winfried Rief
TLTania M. Lincoln
Tania M. Lincoln

5 November 2013 in Psychotherapy Research
Verified
Journal Article
Closed access
EJEsther Jung
Esther Jung
MWMartin Wiesjahn
Martin Wiesjahn
TLTania M. Lincoln
Tania M. Lincoln
Objective: The strength of therapeutic alliance is consistently associated with therapy outcome. The aim of this study was to identify relevant predictors for early therapeutic alliance in cognitive behavioral therapy for psychosis. Method: Fifty-six patients with schizophrenia spectrum disorders were included in the analysis. Possible predictors (positive and negative symptoms, depression, insight, social functioning, theory of mind, and medication adherence) were assessed at baseline. Alliance was assessed after each therapy session. Results: Lower negative symptoms significantly predicted higher patient and therapist rated alliance. Conclusions: The findings indicate that negative symptoms might be a barrier to the development of therapeutic alliance. Assumed underlying processes and practical implications are discussed.

15 November 2012 in Psychosis
Verified
Journal Article
Closed access
MWMartin Wiesjahn
Martin Wiesjahn
ABAlison Brabban
Alison Brabban
EJEsther Jung
Esther Jung
UGUlla B. Gebauer
Ulla B. Gebauer
TLTania M. Lincoln
Tania M. Lincoln

1 October 2016 in Comprehensive Psychiatry
Verified
Journal Article
Closed access
TLTania M. Lincoln
Tania M. Lincoln
EJEsther Jung
Esther Jung
MWMartin Wiesjahn
Martin Wiesjahn
HWHanna Wendt
Hanna Wendt
TBThomas Bock
Thomas Bock
BSBjörn Schlier
Björn Schlier

7 June 2016 in Psychological Medicine
Verified
Journal Article
Closed access
PDF file
EJE. Jung
E. Jung
MWM. Wiesjahn
M. Wiesjahn
HWH. Wendt
H. Wendt
Thomas BockThomas Bock
Thomas Bock
WRW. Rief
W. Rief
TLT. M. Lincoln
T. M. Lincoln
Background: A considerable proportion of people with schizophrenia spectrum disorders do not take antipsychotic medication but seem to be functioning well. However, little is known about this group. To test the assumption that absence of medication is compensated for by more effective coping and increased social support, this study compared symptoms, functioning, coping strategies and social support in non-medicated and medicated individuals with schizophrenia spectrum disorders.Method: In all, 48 participants with a DSM-IV schizophrenia spectrum disorder who were taking (n= 25) or not taking antipsychotic medication (n= 23) were included. Assessment consisted of self-ratings of symptoms, symptom-related distress and social support combined with a semi-structured interview that assessed general and social functioning, subjective evaluation of symptoms and coping strategies.Results: Symptom severity and distress did not differ between the groups. However, the non-medicated participants had significantly higher levels of general functioning than medicated participants and a longer duration of being non-medicated was significantly associated with a higher level of general functioning. In contrast to the hypotheses, not taking medication was not associated with more effective coping strategies or with higher levels of social support. Medicated participants more frequently reported the use of professional help as a coping strategy.Conclusions: Our results corroborate previous studies finding improved functioning in individuals with schizophrenia spectrum disorders who do not take medication compared with those who take medication, but do not support the notion that this difference is explicable by better coping or higher levels of social support. Alternative explanations and avenues for research are discussed.